SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 114 filers reported holding SUTRO BIOPHARMA INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $318,877 | -23.5% | 91,898 | +2.5% | 0.00% | – |
| Q2 2023 | $416,863 | +106514.6% | 89,648 | +5.8% | 0.00% | – |
| Q1 2023 | $391 | -37.7% | 84,696 | +8.9% | 0.00% | -100.0% |
| Q4 2022 | $628 | -99.8% | 77,771 | +9.6% | 0.00% | 0.0% |
| Q3 2022 | $394,000 | +20.5% | 70,984 | +13.1% | 0.00% | – |
| Q2 2022 | $327,000 | -28.0% | 62,756 | +13.7% | 0.00% | -100.0% |
| Q1 2022 | $454,000 | -45.5% | 55,176 | -1.4% | 0.00% | 0.0% |
| Q4 2021 | $833,000 | -20.1% | 55,973 | +1.3% | 0.00% | 0.0% |
| Q3 2021 | $1,043,000 | +5.5% | 55,236 | +3.8% | 0.00% | 0.0% |
| Q2 2021 | $989,000 | +48.5% | 53,211 | +81.9% | 0.00% | 0.0% |
| Q1 2021 | $666,000 | +10.6% | 29,251 | +5.6% | 0.00% | 0.0% |
| Q4 2020 | $602,000 | +192.2% | 27,711 | +35.1% | 0.00% | – |
| Q3 2020 | $206,000 | +41.1% | 20,510 | +9.3% | 0.00% | – |
| Q2 2020 | $146,000 | +3.5% | 18,773 | +36.1% | 0.00% | – |
| Q1 2020 | $141,000 | -7.2% | 13,798 | 0.0% | 0.00% | – |
| Q4 2019 | $152,000 | +23.6% | 13,798 | +1.6% | 0.00% | – |
| Q3 2019 | $123,000 | -12.8% | 13,578 | +9.3% | 0.00% | – |
| Q2 2019 | $141,000 | – | 12,422 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,675,579 | $13,773,000 | 3.47% |
| AJU IB Investment Co., Ltd. | 175,000 | $1,439,000 | 2.22% |
| Frazier Life Sciences Management, L.P. | 1,776,479 | $14,603,000 | 1.24% |
| First Light Asset Management, LLC | 1,672,497 | $13,748,000 | 1.21% |
| BVF INC/IL | 3,447,946 | $28,342,000 | 1.13% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,732,400 | $30,680,000 | 0.94% |
| Endurant Capital Management LP | 296,508 | $2,437,000 | 0.64% |
| Parkman Healthcare Partners LLC | 199,846 | $1,643,000 | 0.48% |
| Eventide Asset Management | 2,708,975 | $22,268,000 | 0.35% |
| Lombard Odier Asset Management (Switzerland) SA | 391,024 | $3,214,000 | 0.25% |